Enhance your practice with CME and tools that focus on the management of neurological conditions.
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Navigating Emerging Biomarkers in MS Care
Ethan Meltzer, MD
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
Discharge Planning After Myasthenic Crisis
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
David Weisman, MD
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Uncovering TK2d: How to Navigate Diagnostic Challenges
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Exploring Genetic Links Between EBV Clearance and MS Risk
Precision Medicine for Myasthenia Gravis
A Closer Look at the Biology Behind MS Progression
Immunologic Phenotyping: The Future of Personalized MG Care
New Therapies, New Strategy: Rethinking MG Inpatient Care
More Than a Myopathy: The Lived Experience of TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.